1. Home
  2. SWAG vs TLPH Comparison

SWAG vs TLPH Comparison

Compare SWAG & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stran & Company Inc.

SWAG

Stran & Company Inc.

N/A

Current Price

$1.70

Market Cap

38.2M

ML Signal

N/A

TLPH

Talphera Inc.

N/A

Current Price

$0.72

Market Cap

37.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SWAG
TLPH
Founded
1994
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.2M
37.9M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
SWAG
TLPH
Price
$1.70
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
30.7K
239.4K
Earning Date
03-27-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$0.38
52 Week High
$3.50
$1.57

Technical Indicators

Market Signals
Indicator
SWAG
TLPH
Relative Strength Index (RSI) 45.03 36.04
Support Level $1.64 $0.41
Resistance Level $1.89 $0.79
Average True Range (ATR) 0.11 0.07
MACD -0.00 -0.01
Stochastic Oscillator 44.83 11.30

Price Performance

Historical Comparison
SWAG
TLPH

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Share on Social Networks: